RASopathies

Gene: MAP2K1

Green List (high evidence)

MAP2K1 (mitogen-activated protein kinase kinase 1)
EnsemblGeneIds (GRCh38): ENSG00000169032
EnsemblGeneIds (GRCh37): ENSG00000169032
OMIM: 176872, Gene2Phenotype
MAP2K1 is in 20 panels

3 reviews

Ivone Leong (Genomics England Curator)

Comment on publications: PMID: 23321623 (publication referring to Noonan syndrome association).
Created: 8 Oct 2020, 10:34 a.m. | Last Modified: 8 Oct 2020, 10:34 a.m.
Panel Version: 1.66

Ellen McDonagh (Genomics England Curator)

Comment on mode of pathogenicity: Activating mutation consequence in G2P. Reviewer Comments: Gain of function mutations in MAP2K1 are responsible for up to 20% of cases of CFC. - Helen Savage (Congenica Ltd), Jan. 21, 2016, 10:31 a.m. Gain of function mutations in MAP2K1 cause Cardio-Facio-cutanenous syndrome and LEOPARD syndrome. These disorders share phenotypes with Legius syndrome. No reports of mutations in MAP2K1 causing Legius syndrome. - Helen Savage (Congenica Ltd), Jan. 25, 2016, 2:55 p.m. Gain of function mutations predicted to be associated with Noonan syndrome in fetuses with abnormal ultrasound findings (see PMID). Possible rare cause of Noonan syndrome; more commonly associated with Cardio-Facio-Cutaenous syndrome and LEOPARD syndrome. - Helen Savage (Congenica Ltd), Jan. 21, 2016, 2:01 p.m.
Created: 5 Feb 2016, 8:55 a.m.
Comment on mode of inheritance: Confirmed on G2P, and not on imprinted gene list.
Created: 5 Feb 2016, 8:48 a.m.
Comment on list classification: Confirmed DD gene for Cardiofaciocutaneous syndrome.
Created: 5 Feb 2016, 8:48 a.m.

Helen Savage (Congenica Ltd)

Green List (high evidence)

Gain of function mutations
Created: 1 Feb 2016, 10:43 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Cardio-Facio-Cutaneous syndrome; LEOPARD syndrome

Mode of pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Eligibility statement prior genetic testing
  • UKGTN
  • Radboud University Medical Center, Nijmegen
Phenotypes
  • Cardiofaciocutaneous syndrome 3, 615279
  • LEOPARD syndrome
  • ?Noonan syndrome
OMIM
176872
Clinvar variants
Variants in MAP2K1
Penetrance
Complete
Publications
Mode of Pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
Panels with this gene

History Filter Activity

8 Oct 2020, Gel status: 3

Set Phenotypes

Ivone Leong (Genomics England Curator)

Phenotypes for gene: MAP2K1 were changed from Cardiofaciocutaneous syndrome 3; Cardiofaciocutaneous Syndrome; Cardio-Facio-Cutaneous syndrome; CFC syndrome; LEOPARD syndrome; ?Noonan syndrome to Cardiofaciocutaneous syndrome 3, 615279; LEOPARD syndrome; ?Noonan syndrome

8 Oct 2020, Gel status: 3

Set publications

Ivone Leong (Genomics England Curator)

Publications for gene: MAP2K1 were set to 21396583; 23321623 (publication referring to Noonan syndrome association).

8 Oct 2020, Gel status: 3

Set publications

Ivone Leong (Genomics England Curator)

Publications for gene: MAP2K1 were set to PMID: 21396583; 23321623 (publication referring to Noonan syndrome association).

5 Feb 2016, Gel status: 4

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for MAP2K1 were set to Cardiofaciocutaneous syndrome 3; Cardiofaciocutaneous Syndrome; Cardio-Facio-Cutaneous syndrome; CFC syndrome; LEOPARD syndrome; ?Noonan syndrome

5 Feb 2016, Gel status: 4

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

5 Feb 2016, Gel status: 4

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for MAP2K1 were set to Cardiofaciocutaneous syndrome 3; Cardiofaciocutaneous Syndrome; Cardio-Facio-Cutaneous syndrome; LEOPARD syndrome; ?Noonan syndrome

5 Feb 2016, Gel status: 4

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for MAP2K1 were set to PMID: 21396583; 23321623 (publication referring to Noonan syndrome association).

5 Feb 2016, Gel status: 4

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for MAP2K1 were set to Cardiofaciocutaneous syndrome 3; Cardiofaciocutaneous Syndrome; Cardio-Facio-Cutaneous syndrome; LEOPARD syndrome

5 Feb 2016, Gel status: 4

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for MAP2K1 were set to PMID: 21396583

5 Feb 2016, Gel status: 4

Set mode of pathogenicity

Ellen McDonagh (Genomics England Curator)

Mode of pathogenicity for MAP2K1 was changed to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

5 Feb 2016, Gel status: 4

Set Mode of Inheritance

Ellen McDonagh (Genomics England Curator)

Mode of inheritance for MAP2K1 was changed to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

5 Feb 2016, Gel status: 4

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

2 Feb 2016, Gel status: 2

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for gene MAP2K1 were set to Cardiofaciocutaneous syndrome 3; Cardiofaciocutaneous Syndrome;Noonan Spectrum Disorders;Cardio-facio-cutaneous syndrome;Noonan syndrome;Noonan syndrome plus other features;Legius syndrome;Costello syndrome;LEOPARD syndrome

2 Feb 2016, Gel status: 2

Upload gene information

Ellen McDonagh (Genomics England Curator)

MAP2K1 was added to RASopathiespanel. Sources: Radboud University Medical Center, Nijmegen,Eligibility statement prior genetic testing,UKGTN

2 Feb 2016, Gel status: 4

clearsources

Ellen McDonagh (Genomics England Curator)

MAP2K1All sources for gene: MAP2K1 were removed

18 Nov 2015, Gel status: 6

Added New Source

Ellen McDonagh (Genomics England Curator)

MAP2K1 was added to RASopathiespanel. Source: Illumina TruGenome Clinical Sequencing Services

18 Nov 2015, Gel status: 4

Added New Source

Ellen McDonagh (Genomics England Curator)

MAP2K1 was added to RASopathiespanel. Source: Illumina TruGenome Clinical Sequencing Services

18 Nov 2015, Gel status: 4

Added New Source

Ellen McDonagh (Genomics England Curator)

MAP2K1 was added to RASopathiespanel. Source: UKGTN

18 Nov 2015, Gel status: 4

Added New Source

Ellen McDonagh (Genomics England Curator)

MAP2K1 was added to RASopathiespanel. Sources: Illumina TruGenome Clinical Sequencing Services,Radboud University Medical Center, Nijmegen,Emory Genetics Laboratory,UKGTN,Eligibility statement prior genetic testing

18 Nov 2015, Gel status: 0

Created

Ellen McDonagh (Genomics England Curator)

MAP2K1 was created by ellenmcdonagh